SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about loss of share certificate

07 Feb 2019 Evaluate

Glaxosmithkline Pharmaceuticals has informed about loss of share certificate / issue of duplicate share certificate.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2413.00 -22.50 (-0.92%)
13-Jul-2026 15:11 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1919.85
Dr. Reddys Labs. 1235.00
Cipla 1426.20
Zydus Lifesciences 1129.70
Lupin 2497.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: